Peregrine Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-387,602
Closed -$4.69M 311
2019
Q4
$4.69M Sell
387,602
-892
-0.2% -$10.8K 0.12% 236
2019
Q3
$5.49M Sell
388,494
-89,549
-19% -$1.27M 0.15% 216
2019
Q2
$5.33M Sell
478,043
-2,466
-0.5% -$27.5K 0.13% 235
2019
Q1
$5.64M Sell
480,509
-1,852
-0.4% -$21.7K 0.14% 241
2018
Q4
$6.44M Buy
482,361
+160,562
+50% +$2.14M 0.18% 221
2018
Q3
$4.51M Buy
+321,799
New +$4.51M 0.11% 239